// App-Quantinova.ai

: Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial

Researchers

Presenter

  • Claudia Valenzuela

Principal Investigators

  • Toby M Maher

  • Francesco Bonella

  • Alberto Pesci

  • Stephane Jouneau

  • Nina M Patel

  • Evans R Fernández Pérez

  • Rainer-Georg Goeldner

  • Susanne Stowasser

  • Rozsa Schlenker-Herceg

  • Manuel Quaresma

  • Vincent Cottin

Medical Centers

  • Hospital Universitario La Paz, Universidad Autonoma de Madrid, Madrid, Spain

  • National Heart and Lung Institute, Imperial College London, UK and National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK, London, United Kingdom

  • Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany

  • Milano-Bicocca University-ASST, Monza, Italy

  • Department of Respiratory Medicine, Competences Centre for Rare Pulmonary Diseases, Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail - UMR_S 1085, F-35000 Rennes, France

  • Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, NY, United States of America

  • National Jewish Health, Denver, CO, United States

  • Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, United States.

  • National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France,

Locations

  • Spain

  • United Kingdom

  • Germany

  • Italy

  • France

  • United States

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved